AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitagreen M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Auxesia Life Sciences Private Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitagreen M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering the risk of stroke or heart attack. Diabex Duo may be used independently or in conjunction with other diabetes treatments. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under a physician's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, particularly when used with insulin or sulfonylureas; learn to recognize and manage this risk. This medication isn't suitable for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should consult their physician. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be minimized due to its blood glucose-lowering effects. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Uses of Sitagreen M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitagreen M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sitagreen M 50mg/500mg Tablet should be administered with food.

Common Side effects of Sitagreen M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitagreen M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitagreen M 50mg/500mg tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Sitagreen M 50mg/500mg Tablet works:

Sitagliptin and metformin, combined as Sitagreen M 50mg/500mg tablets, offer enhanced blood glucose management. Sitagliptin stimulates the pancreas to increase insulin production, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This synergistic action leads to superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitagreen M 50mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitagreen M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Nursing mothers should likely avoid Sitagreen M 50mg/500mg tablets. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitagreen M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. The medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with hepatic impairment should likely refrain from using Sitagreen M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitagreen M 50mg/500mg Tablet :

Should you forget a Sitagreen M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitagreen M 50mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Sitagreen M 50mg/500mg Tablet

Sitagliptin and Metformin, combined as Sitagreen M 50mg/500mg tablets, manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and enhances insulin sensitivity. Sitagliptin's action involves DPP4 enzyme inhibition, promoting increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged use of Sitagreen M 50mg/500mg tablets can indeed lead to vitamin B12 deficiency. This medication impairs the body's ability to absorb vitamin B12 from the digestive tract. Untreated deficiency can manifest as anemia and neurological issues, including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental vitamin B12 is recommended annually by some experts.
Sitagreen M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitagreen M 50mg/500mg Tablet constituents or inactive ingredients should not use this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitagreen M 50mg/500mg Tablet is unsafe due to a heightened risk of lactic acidosis.
Retain this medication within its original, tightly sealed container. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Sitagliptin/metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates avoiding the medication in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches, weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Sitagliptin/metformin and prompt medical attention.
Sitagliptin and Metformin, combined as Sitagreen M 50mg/500mg tablets, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's mechanism involves DPP4 enzyme inhibition, leading to increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitagreen M 50mg/500mg tablets may cause common side effects including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any ingredient or inactive substance in Sitagreen M 50mg/500mg Tablets should not use this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitagreen M 50mg/500mg Tablet is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution, particularly for individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms may present as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin/metformin and seek immediate medical attention.
Prolonged consumption of Sitagreen M 50mg/500mg Tablets can lead to Vitamin B12 deficiency. This medication impairs the body's absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Sitagliptin and Metformin, combined as Sitagreen M 50mg/500mg tablets, treat type 2 diabetes mellitus. This medication enhances blood sugar control in adults when coupled with a healthy diet and physical activity. Metformin reduces liver glucose output and improves insulin responsiveness. Sitagliptin blocks the DPP4 enzyme, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitagreen M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitagreen M 50mg/500mg Tablet constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitagreen M 50mg/500mg Tablet is unsafe due to a heightened risk of lactic acidosis.
Sitagliptin/metformin combination tablets (e.g., Sitagreen M 50mg/500mg) may cause lactic acidosis, a serious medical condition characterized by excessive blood lactate. This complication, also termed metformin-associated lactic acidosis (MALA), is infrequent but warrants caution. Its occurrence is increased in patients with pre-existing kidney impairment, advanced age, or significant alcohol consumption; therefore, such individuals should avoid this medication. Symptoms potentially indicative of lactic acidosis encompass muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Sitagliptin/metformin immediately and seek urgent medical attention.
Prolonged Sitagreen M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This medication impedes the stomach's absorption of vitamin B12. Consequently, untreated deficiency can manifest as anemia and neurological issues, including peripheral paresthesia (tingling and numbness in the extremities), weakness, urinary dysfunction, cognitive changes, and ataxia (balance impairment). Preventive measures, as proposed by some studies, involve supplemental vitamin B12 intake at least annually.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the label or packaging. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Sitagreen M 50mg/500mg Ta...
68
MRP 79
13% off